Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 32,200 KRW
Change Today 0.00 / 0.00%
Volume 195.0K
000230 On Other Exchanges
Korea SE
As of 12:01 AM 08/5/15 All times are local (Market data is delayed by at least 15 minutes).

il dong pharmaceutical co lt (000230) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/6/15 - 41,850
52 Week Low
08/8/14 - 13,450
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IL DONG PHARMACEUTICAL CO LT (000230)

Related News

No related news articles were found.

il dong pharmaceutical co lt (000230) Related Businessweek News

No Related Businessweek News Found

il dong pharmaceutical co lt (000230) Details

Ildong Pharmaceutical Co., Ltd. provides various pharmaceutical products in South Korea. The company offers active lactic acid bacteria and anti-diarrheal agents, antibiotics, antifungals and antivirals, anti-histamine drugs, antineoplastic agents, NSAIDs and analgesics, topical preparations, vitamins, and mineral and nutrients; and drugs for blood circulation, cardiovascular system, central nervous system, dental treatment, endocrine and metabolic systems, gastrointestinal system, respiratory system, and urogenital system. It also provides raw material drugs, such as synthesis, probiotics, and biometabolites; health foods and foods; cosmetics; medical devices; and other products. The company also exports its products to Japan, Vietnam, Azerbaijan, Cambodia, Dominican Republic, Guatemala, Indonesia, Malaysia, Mexico, Myanmar, Pakistan, the Philippines, Singapore, Vietnam, Yemen, etc. The company was formerly known as Keukdong Pharmaceuticals Co., Ltd. and changed its name to Ildong Pharmaceutical Co., Ltd. in May 1942. The company was founded in 1941 and is headquartered in Seoul, South Korea.

Founded in 1941

il dong pharmaceutical co lt (000230) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

il dong pharmaceutical co lt (000230) Key Developments

Ildong Pharmaceutical Co., Ltd.(KOSE:A000230) added to KOSPI 200 Index

Ildong Pharmaceutical Co., Ltd. has been added to KOSPI 200 Index.

Ildong Pharmaceutical Reports Earnings Results for the First Quarter of 2015

Ildong Pharmaceutical reported earnings results for the first quarter of 2015. For the quarter, the company posted a 31.4% year on year rise in revenue to KRW 114.9 billion. Operating profit for the quarter jumped 256% year on year to KRW 12.1 billion.

Ildong Pharmaceutical Co., Ltd., Annual General Meeting, Mar 20, 2015

Ildong Pharmaceutical Co., Ltd., Annual General Meeting, Mar 20, 2015., at 10:00 Korea Standard Time. Location: 27 way 2 Nitto Pharmaceutical headquarters auditorium. Agenda: To consider the audit report, business report, external audit report appointment; to consider financial statements and consolidated financial statements; to consider appointment of Independent candidates; to consider appointment auditor; to consider approval of remuneration ceiling bill; and to consider approval of audit fees limit.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000230:KS 32,200.00 KRW 0.00

000230 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000230.
View Industry Companies

Industry Analysis


Industry Average

Valuation 000230 Industry Range
Price/Earnings 59.1x
Price/Sales 1.7x
Price/Book 2.1x
Price/Cash Flow 49.1x
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IL DONG PHARMACEUTICAL CO LT, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at